About
Dynocardia, Inc. is a Boston-based medical device company founded in September 2018. The company focuses on developing innovative biomedical technologies to enhance healthcare globally. Dynocardia emerged from research at MIT and Tufts Medical, with support from NIH grants. Its flagship product, ViTrack™, is a first-of-its-kind, cuff-less wearable device designed for continuous, non-invasive blood pressure monitoring. ViTrack™ utilizes a proprietary optical force sensor and advanced motion-correction algorithms to provide accurate beat-to-beat blood pressure readings. In addition to blood pressure, the device also measures heart rate, heart rhythm, and respiratory metrics, making it suitable for various applications, including outpatient diagnosis, in-hospital monitoring, and remote patient care. Dynocardia is actively engaged in clinical validation and regulatory processes to bring its technology to market, targeting healthcare providers, hospitals, and consumers interested in wellness and disease prevention.
Technologies
Keywords
Company Information
- Employees22
- Founded2018
- Total Funding$7715323
Location
1 Broadway, Cambridge, Massachusetts, United States, 02142
